Navigation Links
Examining the Lacey Act
Date:9/11/2007

Andrea Fowler, David Lodge, and Jennifer Hsia (University of Notre Dame) examined the efficacy of the Lacey Act in their research communication, Failure of the Lacey Act to protect US ecosystems against animal invasions. The study appears in the September issue of Frontiers in Ecology and the Environment.

With over 100 years on the books (passed in 1900), the Lacey Act is the main legal defense against invasive animal species. The injurious wildlife provision of the Lacey Act seeks to regulate foreign invasive species that may damage ecosystems, replace native populations, and kill off valuable natural resources and fisheries.

If the US is to reduce the probability of future damage from invasive animal species, revision or replacement of the Lacey Acts injurious wildlife provision is essential, say the authors. The contemporary threat of invasive species has far outstripped current authority and practice under this statute.

Examining all Federal Register documents, Fowler and colleagues searched the listed names of organisms, references to the Lacey Act, and references to injurious wildlife to determine which species were listed, considered for listing, and either added or not added to the list.

Many animals were already established when they were added to the list and continued to spread after their listing. The most common way to begin the process of listing a species in the last 25 years has been by petitioning the U.S. Fish and Wildlife Service. However, by March 1, 2007, when the authors wrote the paper, it took an average of more that three and a half years to list a species in this way.

According to the report, the lack of an efficient and consistently applied risk assessment procedure undermine the Lacey Act. Currently, most imported species only need to be declared to customs or permitted through the US Fish and Wildlife Service. The act was expanded from mammals and birds to include mollusks, crustaceans, reptiles, and amphibians in the late 1960s and early 1980s. In the 1970s there was a movement to limit importation to a list of low-risk wildlife, but the list was never implemented.

Fowler et. al. point out that the Lacey Act contains no authority or funding to manage the spread of established wild invasive species, which will do little to slow down organisms already present in the US.

The researchers suggest that prescreening, as well as switching from the use of a list of banned animals to approved species, would better protect the nations environment and natural resources.


'/>"/>

Contact: Annie Drinkard
annie@esa.org
Ecological Society of America
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
(Date:2/23/2017)... Aviva Systems Biology Corporation (ASB) which ... GenWay Biotech Incorporated, a protein solutions and applications ... for both the research and diagnostic markets. ... capabilities for both entities. GenWay,s 18 years of experience ... complement ASB,s objective to become a leading provider ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... announced that is has acquired Kendall Research Systems, LLC (KRS) clinical ... (MIT) that develops neural interface technology for research and clinical applications. The terms ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... medical education provider of women’s health, primary care, and specialty education, announced ... Continuing Medical Education (ACCME). ACCME’s Accreditation with Commendation is a six-year accreditation ...
Breaking Biology Technology: